Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 286-293, February 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spar, I. L.
Right arrow Articles by Izzo, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spar, I. L.
Right arrow Articles by Izzo, M. J.

Preparation of Purified I131-labeled Antibody Which Reacts with Human Fibrin. Preliminary Tracer Studies on Tumor Patients*

Irving L. Spar, William F. Bale, Ruth L. Goodland and Mary Jane Izzo

( Department of Radiation Biology, University of Rochester, School of Medicine and Dentistry, Rochester, New York)

Technics are described for preparing, from sera of rabbits immunized with human fibrinogen, I131-labeled antibody reacting with fibrin and suitable for diagnostic use as an intravenously administered tracer in human patients. The final purified sterile preparations contained I131 label at a level of approximately 10 mc I131/mg rabbit antibody protein. The labeled preparation almost quantitatively bound to freshly formed human fibrin in the presence of the serum proteins but did not bind to rabbit fibrin.

Twenty-eight human patients have been given injections intravenously of this type of preparation with no untoward effects. Scintillation scanning of the head area of those patients with known or suspected brain tumors indicated that preparations of this type may be useful for diagnosis and delineation of those lesions.

Possibilities of increasing the effective preferential localization of this radioactive material in tumors for diagnostic or therapeutic purposes by the concurrent use of epsilon amino caproic acid, or other inhibitors of plasminogen activation or plasmin activity, are discussed.

* This paper is based on work performed under contract with the United States Atomic Energy Commission at the University of Rochester Atomic Energy Project, Rochester, New York.

Received 8/12/63.


This article has been cited by other articles:


Home page
ScienceHome page
M. L. Varon and L. J. Cole
Hemopoietic Colony-Forming Units in Regenerating Mouse Liver: Suppression by Anticoagulants
Science, August 5, 1966; 153(3736): 643 - 644.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.